RE:RE:RE:RE:RE:RE:RE:RE:RE:In North AmericaVenowave at $10M/year is a great start. If this can get further licensed, it will be good. Hopefully Acuvid can be used to test the common flu as well. we can talk as much as we want, but the next news release will explain all. Cheer's to a good month.